Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-09-09
1996-12-03
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514211, A61K 3155
Patent
active
055808670
ABSTRACT:
Myocardial protection is achieved by administering to a patient an effective amount of a benzothiazepine derivative. The benzothiazepine derivatives have the following general chemical formula: ##STR1## wherein R.sub.1 represents hydrogen or methyl,
REFERENCES:
patent: 4520112 (1985-05-01), Snyder et al.
patent: 4743599 (1988-05-01), Muller
patent: 4902684 (1990-02-01), Floyd
patent: 4950663 (1990-08-01), Dumont et al.
Nagao Chem Pharm. Bull 21 1, p. 92 (1973) Abst.
Tanguay J Cardiovasc. Pharmacol. 24 #6 p. 950, 1994 Abs.
Multicenter Diltiazem Postinfarction Trial Research Group, New Eng. J. Med., 319:385-92 (1988).
Grover et al., J. Pharmacology and Exp. Therapeutics, 246:263-69 (1988).
Moss et al., Circulation, Supp IV, 80:102-06 (1989).
Grover et al., J. Cardiovascular Pharmocol., 16:219-27 (1990).
Rousseau et al., Cardiovascular Research, vol. XXV, No. 4, pp. 319-329 (1991).
Goldstein et al., Circulation 83:52-60 (1991).
Poole-Wilson, Am. J. Cardiology, 75:4E-9E (1995).
Tanguay et al., J. Cardiovascular Pharmacol., 24:950-59 (1994).
Kiyomoto et al., Circ. Res., 52 (Supp I): 115-19 (1983).
Nasa et al., J. Pharmacol. and Exp. Therapeutics, 255 (2):680-89 (1990).
Bourassa et al., Chest, 78:1 (Supp) pp. 224-30 (Jul. 1980).
Rovelli et al., Lancet, Feb. 22, 1986, pp. 397-401.
Reimer et al., Circulation, 56 (5):786-94 (1977).
Braunwald et al., J. Clin. Invest., 76:1713-19 (1985).
Schofer et al., JACC, 5 (3):593-98 (1985).
Lorgeril et al., Am. J. Cardiovascular Pathology, 3 (2):143-54 (1990).
Rousseau et al., J. Cardiovascular Pharmacol., 22:264-72 (1993).
Rousseau et al., J. Pharmacol. and Exp. Therapeutics, 268 (3):1252-60 (1994).
Roberts, Circulation, (Supp IV) 80 (6) IV:93-101 (1989).
Messerli et al., Am. J. Cardiology, 72:818-20 (1993).
Schwartz et al., J. Org. Chem., 57:851-56 (1992).
Rousseau et al., Am. Heart J., 125 (6):1553-63 (1993).
Li et al., J. Med. Chem., 35:3246-53 (1992).
Product sheet for "Cardizem SR", Medicine North America, 36 p. 6558 (1989).
Merck Index, Entry 3189 "Diltiazem", 10th Ed. (1983).
Beno it Serge
Gravel Denis
Latour Jean-Gilles
Wang Yuan
Kishore Gollamudi S.
Universite de Montreal
LandOfFree
Myocardial protection during ischemia and reperfusion does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Myocardial protection during ischemia and reperfusion, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Myocardial protection during ischemia and reperfusion will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-785735